COMPASS THERAPEUTICS, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
COMPASS THERAPEUTICS, INC. (CMPX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $5.38 thousand for the 12-month period ending 2020-03-31, per its 10-K filed 2020-06-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2020-06-08
- COMPASS THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2020-03-31 was -$1.46K.
- COMPASS THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2019-12-31 was $4.44K.
- COMPASS THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2019-09-30 was -$9.07K, a 340.41% decline year-over-year.
- COMPASS THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2019-06-30 was $11.46K, a 1876.21% increase year-over-year.
- COMPASS THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2020 was $5.38K, a 64.03% increase from fiscal 2019.
- COMPASS THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2019 was $3.28K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 0 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2020-03-31 | -$1.46K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-08 | $2.98K derived: sum of 2 quarters · filed 2020-06-08 | -$6.08K derived: sum of 3 quarters · filed 2020-06-08 | $5.38K 10-K · filed 2020-06-08 | |
| 2019-12-31 | $4.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-14 | -$4.62K derived: sum of 2 quarters · filed 2020-02-14 | $6.84K 10-Q · filed 2020-02-14 | $5.89K derived: sum of 4 quarters · filed 2020-06-08 | |
| 2019-09-30 | -$9.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-13 | $2.40K 10-Q · filed 2019-11-13 | $1.45K derived: sum of 3 quarters · filed 2020-06-08 | $1.32K derived: sum of 4 quarters · filed 2020-06-08 | |
| 2019-06-30 | $11.46K 10-Q · filed 2019-08-13 | $10.51K derived: sum of 2 quarters · filed 2020-06-08 | $10.39K derived: sum of 3 quarters · filed 2020-06-08 | $14.16K derived: sum of 4 quarters · filed 2020-06-08 | |
| 2019-03-31 | -$948.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-08 | -$1.07K derived: sum of 2 quarters · filed 2020-06-08 | $2.70K derived: sum of 3 quarters · filed 2020-06-08 | $3.28K 10-K · filed 2020-06-08 | |
| 2018-12-31 | -$125.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-14 | $3.65K derived: sum of 2 quarters · filed 2020-02-14 | $4.23K 10-Q · filed 2020-02-14 | ||
| 2018-09-30 | $3.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-13 | $4.35K 10-Q · filed 2019-11-13 | |||
| 2018-06-30 | $580.00 10-Q · filed 2019-08-13 | ||||
| 2018-03-31 | $52.00 10-K · filed 2019-07-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |